Investing in innovation to tackle health care’s biggest challenges
At Independence, we believe strongly in investing in the future to transform health care – bring you care that’s simpler, higher quality and more affordable. Through our $50-million Strategic Innovation Portfolio, we invest capital, expertise, and other resources into companies of any stage that are focused on bringing innovation to health care through new technologies, products, and services. We also invest in health-related venture funds and early stage companies, including start-ups in Dreamit Health.
Currently, the companies we have invested in include:
- Biomeme, a very low-cost point of care diagnostic platform that provides real-time test results that close care gaps and improve outcomes.
- Accolade, which provides customer service to employees using leading technology and analytics and offering tailored, personal guidance for making important medical decisions.
- Array Health, which enhances the consumer experience shopping for health care coverage on private health insurance exchanges.